Research Peptides
A high-purity research peptide studied in immune research. Available in 5mg and 10mg, with every batch independently tested and dispatched from the UK.
A high-purity research peptide studied in immune research. Available in 5mg and 10mg, with every batch independently tested and dispatched from the UK.
Thymosin Alpha-1 peptide UK is Crown Peptides' synthetic 28-amino-acid thymic peptide, supplied in 5mg and 10mg vials for laboratory research into T-cell maturation, dendritic-cell biology and immune signalling.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Thymosin Alpha-1 is a 28-amino-acid peptide originally identified from thymic peptide preparations. It is widely used in immunology research because experimental work has linked it with T-cell function, dendritic-cell signalling and interactions between innate and adaptive immune pathways.
Thymosin Alpha-1 research includes T-cell maturation and activation, dendritic-cell biology, toll-like receptor pathways, cytokine signalling and immune responses to experimental infectious or inflammatory challenges, including documented activation of dendritic cells through toll-like-receptor signalling (Learn more). Its research profile is broader than simple immune stimulation, with studies examining how it can modulate different arms of immune signalling depending on context, alongside related host-defence and immune-research peptides such as [LL-37] and [KPV].
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides Thymosin Alpha-1 is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification. The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with Thymosin Alpha-1 may also be interested in [LL-37], [KPV], [TB-500], [ARA-290] and [Kisspeptin-10] — other immune and signalling-research peptides studied in related research areas.
Thymosin Alpha-1 is a 28-amino-acid thymic peptide widely studied in immunology, supplied by Crown Peptides in 5mg and 10mg vials.
Research includes T-cell biology, dendritic cells, toll-like receptor pathways, cytokine signalling and innate/adaptive immune responses.
No. They are distinct peptides with different sequences and research profiles.
Experimental studies examine changes across multiple immune pathways rather than a single one-directional immune effect.
HPLC and Mass Spectrometry can assess peptide identity and purity, with exact sequence/form and batch results documented on the CoA.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.